These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

272 related articles for article (PubMed ID: 21952036)

  • 1. Glucokinase activation repairs defective bioenergetics of islets of Langerhans isolated from type 2 diabetics.
    Doliba NM; Qin W; Najafi H; Liu C; Buettger CW; Sotiris J; Collins HW; Li C; Stanley CA; Wilson DF; Grimsby J; Sarabu R; Naji A; Matschinsky FM
    Am J Physiol Endocrinol Metab; 2012 Jan; 302(1):E87-E102. PubMed ID: 21952036
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Glucagon-like peptide-1 and islet lipolysis.
    Sörhede Winzell M; Ahrén B
    Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment with exendin-4 improves the antidiabetic efficacy and reverses hepatic steatosis in glucokinase activator treated db/db mice.
    Dhanesha N; Joharapurkar A; Shah G; Kshirsagar S; Patel V; Patel K; Bahekar R; Jain M
    Eur J Pharmacol; 2013 Aug; 714(1-3):188-92. PubMed ID: 23810686
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Glucose-dependent modulation of insulin secretion and intracellular calcium ions by GKA50, a glucokinase activator.
    Johnson D; Shepherd RM; Gill D; Gorman T; Smith DM; Dunne MJ
    Diabetes; 2007 Jun; 56(6):1694-702. PubMed ID: 17360975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Glucagon-like peptide-1 induced signaling and insulin secretion do not drive fuel and energy metabolism in primary rodent pancreatic beta-cells.
    Peyot ML; Gray JP; Lamontagne J; Smith PJ; Holz GG; Madiraju SR; Prentki M; Heart E
    PLoS One; 2009 Jul; 4(7):e6221. PubMed ID: 19593440
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Medicine. Drug deals diabetes a one-two punch.
    Couzin J
    Science; 2003 Jul; 301(5631):290. PubMed ID: 12869732
    [No Abstract]   [Full Text] [Related]  

  • 7. The glucagon-like peptide-1 receptor agonist exenatide restores impaired pro-islet amyloid polypeptide processing in cultured human islets: implications in type 2 diabetes and islet transplantation.
    Park YJ; Ao Z; Kieffer TJ; Chen H; Safikhan N; Thompson DM; Meloche M; Warnock GL; Marzban L
    Diabetologia; 2013 Mar; 56(3):508-19. PubMed ID: 23262664
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Exendin-4 ameliorates diabetic symptoms through activation of glucokinase.
    Dhanesha N; Joharapurkar A; Shah G; Dhote V; Kshirsagar S; Bahekar R; Jain M
    J Diabetes; 2012 Dec; 4(4):369-77. PubMed ID: 22356440
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Effects of exendin-4 on islets from type 2 diabetes patients.
    Lupi R; Mancarella R; Del Guerra S; Bugliani M; Del Prato S; Boggi U; Mosca F; Filipponi F; Marchetti P
    Diabetes Obes Metab; 2008 Jun; 10(6):515-9. PubMed ID: 18201204
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Insulinotropic actions of exendin-4 and glucagon-like peptide-1 in vivo and in vitro.
    Parkes DG; Pittner R; Jodka C; Smith P; Young A
    Metabolism; 2001 May; 50(5):583-9. PubMed ID: 11319721
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Allosteric activators of glucokinase: potential role in diabetes therapy.
    Grimsby J; Sarabu R; Corbett WL; Haynes NE; Bizzarro FT; Coffey JW; Guertin KR; Hilliard DW; Kester RF; Mahaney PE; Marcus L; Qi L; Spence CL; Tengi J; Magnuson MA; Chu CA; Dvorozniak MT; Matschinsky FM; Grippo JF
    Science; 2003 Jul; 301(5631):370-3. PubMed ID: 12869762
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Concordant glucose induction of glucokinase, glucose usage, and glucose-stimulated insulin release in pancreatic islets maintained in organ culture.
    Liang Y; Najafi H; Smith RM; Zimmerman EC; Magnuson MA; Tal M; Matschinsky FM
    Diabetes; 1992 Jul; 41(7):792-806. PubMed ID: 1612193
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Prolonged culture of human pancreatic islets under glucotoxic conditions changes their acute beta cell calcium and insulin secretion glucose response curves from sigmoid to bell-shaped.
    Tariq M; de Souza AH; Bensellam M; Chae H; Jaffredo M; Close AF; Deglasse JP; Santos LRB; Buemi A; Mourad NI; Wojtusciszyn A; Raoux M; Gilon P; Broca C; Jonas JC
    Diabetologia; 2023 Apr; 66(4):709-723. PubMed ID: 36459178
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Evaluating insulin secretagogues in a humanized mouse model with functional human islets.
    Luo J; Nguyen K; Chen M; Tran T; Hao J; Tian B; Rulifson IC; Zhang Y; Tian L; Zhang Y; Lopez E; Lin DC; Wang Y; Ma Z; Houze J; Guo Z
    Metabolism; 2013 Jan; 62(1):90-9. PubMed ID: 22982177
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Defective stimulus-secretion coupling in islets of Psammomys obesus, an animal model for type 2 diabetes.
    Nesher R; Warwar N; Khan A; Efendic S; Cerasi E; Kaiser N
    Diabetes; 2001 Feb; 50(2):308-14. PubMed ID: 11272141
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Tacrolimus suppresses glucose-induced insulin release from pancreatic islets by reducing glucokinase activity.
    Radu RG; Fujimoto S; Mukai E; Takehiro M; Shimono D; Nabe K; Shimodahira M; Kominato R; Aramaki Y; Nishi Y; Funakoshi S; Yamada Y; Seino Y
    Am J Physiol Endocrinol Metab; 2005 Feb; 288(2):E365-71. PubMed ID: 15479952
    [TBL] [Abstract][Full Text] [Related]  

  • 17. In vitro effects of bis(1,2-dimethyl-3-hydroxy-4-pyridinonato)oxidovanadium(IV), or VO(dmpp)2, on insulin secretion in pancreatic islets of type 2 diabetic Goto-Kakizaki rats.
    Pelletier J; Domingues N; Castro MM; Östenson CG
    J Inorg Biochem; 2016 Jan; 154():29-34. PubMed ID: 26559485
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The potential role of glucokinase activator SHP289-04 in anti-diabetes and hepatic protection.
    Lei L; Liu S; Li Y; Song H; He L; Liu Q; Sun S; Li Y; Feng Z; Shen Z
    Eur J Pharmacol; 2018 May; 826():17-23. PubMed ID: 29477658
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Durable islet effects on insulin secretion and protein kinase A expression following exendin-4 treatment of high-fat diet-fed mice.
    Winzell MS; Ahrén B
    J Mol Endocrinol; 2008 Feb; 40(2):93-100. PubMed ID: 18234911
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Changes induced by sucrose administration on glucose metabolism in pancreatic islets in normal hamsters.
    Massa ML; Borelli MI; Del Zotto H; Gagliardino JJ
    J Endocrinol; 2001 Dec; 171(3):551-6. PubMed ID: 11739021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 14.